Revenue

9 Months Ended

Mar. 31, 2023

Revenue

Revenue [Text Block]

Note 6. Revenue

As of March 31, 2023 and June 30, 2022, the net rebate receivable (liability) was $5,612 and ($217,158), respectively. The rebate receivable is included in other receivables and rebate liability is included in accrued expenses within the accompanying condensed consolidated balance sheets. As of March 31, 2023 and June 30, 2022, the allowance for sales discounts was $12,946 and $17,632, respectively. The allowance for sales discounts is included in trade accounts receivable, less allowance for doubtful accounts in the accompanying condensed consolidated balance sheets.

The following table disaggregates revenue by major product category for the three and nine months ended March 31:

		Three Months Ended March 31,				Nine Months Ended March 31,
		2023		2022		2023		2022
Physical Therapy and Rehabilitation Products	$	4,735,741	$	4,810,043	$	17,399,296	$	16,934,423
Orthopedic Soft Bracing Products		4,476,849		5,476,469		14,698,238		16,126,728
Other		23,447		29,741		74,260		85,850
	$	9,236,037	$	10,316,253	$	32,171,794	$	33,147,001